Amicus Therapeutics has acquired 2 companies of its own.
Amicus Therapeutics’ largest acquisition to date was in 2015, when it acquired Scioderm for $229M. Amicus Therapeutics has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).
47 Hulfish Street,
Princeton, New Jersey
08542
United States,
(609) 662-2000
www.amicusrx.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2018-09-20 |
Celenex · Life Science
Columbus, Ohio Celenex is a clinical stage gene therapy company. The lead programs in CLN6, CLN3, and CLN8 Batten disease are potential first-to-market curative therapies for these rare, devastating diseases. Celenex is based in Columbus, Ohio. Advisors: Fenwick & West , RBC Capital Markets |
175 | Add-on Acquisition |
Amicus Therapeutics
|
- |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
